UNIVERSE PHARMACEUTICALS, INC. - Ordinary Shares, $0.01875 par value (UPC)

Q: What does CUSIP G9442G104 represent in this 13F holders report?

CUSIP G9442G104 is the security identifier for UPC - UNIVERSE PHARMACEUTICALS, INC. - Ordinary Shares, $0.01875 par value used to aggregate holder disclosures.

Q: How many institutions held UPC - UNIVERSE PHARMACEUTICALS, INC. - Ordinary Shares, $0.01875 par value in Q1 2022?

4 institutional investors reported UPC - UNIVERSE PHARMACEUTICALS, INC. - Ordinary Shares, $0.01875 par value for Q1 2022. Use the holders table for investor-level position and value details.

CUSIP: G9442G104

Q1 2022 13F Holders as of 31 Mar 2022

Security type / class: Equity / Ordinary Shares, $0.01875 par value
Total 13F shares: 1,107,394
Total 13F value: $1,401,000
Share change: -85,748
SEC-reported price per share: $1.27
Number of holders: 4
Value change: -$128,863
Number of sells: 4
Shares outstanding: 7,902,293

Security key

G9442G104

Report period

Q1 2022

Institutions

Top holders

UPC full security history Ownership snapshot Full 13F holder table Universe Pharmaceuticals INC SEC filings Universe Pharmaceuticals INC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of UPC - UNIVERSE PHARMACEUTICALS, INC. - Ordinary Shares, $0.01875 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

PURA VIDA INVESTMENTS, LLC

Disclosed value leader

PURA VIDA INVESTMENTS, LLC

Comparable rows

5/5

Latest evidence

31 Dec 2021

13F Lead comparable stake: 14%

Quick read

PURA VIDA INVESTMENTS, LLC leads the comparable SEC ownership view at 14%.

5 of 5 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PURA VIDA INVESTMENTS, LLC's linked filing trail.

Comparable ownership Top 5

PURA VIDA INVESTMENTS, LLC 14%

CITADEL ADVISORS LLC 0.48%

RENAISSANCE TECHNOLOGIES LLC 0.25%

ACADIAN ASSET MANAGEMENT LLC 0.17%

UBS Group AG 0.09%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-5 of 5 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
PURA VIDA INVESTMENTS, LLC	13F Company 13F	14%	$1,823,000 1,115,085 shares	—	31 Dec 2021
CITADEL ADVISORS LLC	13F Company 13F	0.48%	$62,000 38,078 shares	—	31 Dec 2021
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	0.25%	$32,000 19,820 shares	—	31 Dec 2021
ACADIAN ASSET MANAGEMENT LLC	13F Company 13F	0.17%	$21,000 13,299 shares	—	31 Dec 2021
UBS Group AG	13F Company 13F	0.09%	$11,000 6,860 shares	—	31 Dec 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,107,394

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q1 2022 value	Q1 2022 value	Value change	Value Chg %